Hyloris Pharmaceuticals S.A.

HYL.BR · BRU
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€23,594€30,406€43,457€50,012
Short-Term Investments€556€0€0€528
Receivables€4,858€3,565€4,127€2,321
Inventory€0€0€0€0
Other Curr. Assets€699€1,337€2,217€1,098
Total Curr. Assets€29,707€35,308€49,801€53,959
Property Plant & Equip (Net)€1,992€2,153€1,060€295
Goodwill€0€0€0€0
Intangibles€3,838€3,828€3,607€2,944
Long-Term Investments€3,748€4,801€4,479€4,004
Tax Assets€0€0-€4,479€528
Other NC Assets€2,050€1,591€6,396€1,714
Total NC Assets€11,628€12,373€11,063€9,485
Other Assets€0€0€0€0
Total Assets€41,335€47,681€61,864€63,444
Liabilities
Payables€3,428€3,195€2,302€2,622
Short-Term Debt€326€241€3,488€11,880
Tax Payable€0€0€0€349
Deferred Revenue€0€0€0€0
Other Curr. Liab.€3,408€3,323€34€127
Total Curr. Liab.€7,162€6,759€5,772€14,978
LT Debt€1,489€1,510€747€409
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€541€343€300€1
Total NC Liab.€2,030€1,853€1,047€410
Other Liabilities€0€0€0€0
Cap. Leases€1,815€1,751€885€174
Total Liabilities€9,192€8,612€6,819€15,388
Equity
Pref Stock€0€0€2,362€960
Common Stock€140€140€140€129
Retained Earnings-€86,470-€80,761-€65,381-€54,805
AOCI-€3,516-€1,823-€2,362-€960
Other Equity€121,989€121,513€119,150€102,732
Total Equity€32,143€39,069€53,909€48,056
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€41,335€47,681€61,864€63,444
Net Debt-€21,779-€28,655-€39,222-€37,723
Hyloris Pharmaceuticals S.A. (HYL.BR) Financial Statements & Key Stats | AlphaPilot